Literature DB >> 22552038

Relative effectiveness of oral 25-hydroxyvitamin D3 and vitamin D3 in raising wintertime serum 25-hydroxyvitamin D in older adults.

Kevin D Cashman1, Kelly M Seamans, Alice J Lucey, Elisabeth Stöcklin, Peter Weber, Mairead Kiely, Tom R Hill.   

Abstract

BACKGROUND: The relative potency of 25-hydroxyvitamin D3 to vitamin D3 needs to be better defined so that food-composition tables can better reflect the true vitamin D nutritive value of certain foods.
OBJECTIVE: We performed a randomized, controlled intervention study in apparently healthy, free-living adults to investigate whether the intake of 25-hydroxyvitamin D3 is 5 times more potent in raising serum 25-hydroxyvitamin D [25(OH)D] during winter compared with an equivalent amount of vitamin D3.
DESIGN: A randomized, placebo-controlled, double-blind intervention study was conducted in adults aged ≥50 y (n = 56) who consumed a placebo, 20 μg vitamin D3, or 7 or 20 μg 25-hydroxyvitamin D3 daily throughout 10 wk of winter. Serum 25(OH)D was measured by using an enzyme-linked immunoassay, and serum albumin-corrected calcium (S-Ca) was assessed colorimetrically at the baseline, midpoint, and endpoint of the study.
RESULTS: The mean (±SD) increases (per microgram of vitamin D compound) in serum 25(OH)D concentrations over baseline after 10 wk of supplementation were 0.96 ± 0.62, 4.02 ± 1.27, and 4.77 ± 1.04 nmol · L(-1) · μg intake(-1) for the 20-μg vitamin D3/d and 7- and 20-μg 25-hydroxyvitamin D3/d groups, respectively. A comparison of the 7- and 20-μg 25-hydroxyvitamin D3/d groups with the 20-μg vitamin D3/d group yielded conversion factors of 4.2 and 5, respectively. There was no effect of treatment on S-Ca concentrations and no incidence of hypercalcemia (S-Ca >2.6 nmol/L).
CONCLUSIONS: Each microgram of orally consumed 25-hydroxyvitamin D3 was about 5 times more effective in raising serum 25(OH)D in older adults in winter than an equivalent amount of vitamin D3. This conversion factor could be used in food-compositional tables for relevant foods. This study was registered at clinicaltrials.gov as NCT01398202.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552038     DOI: 10.3945/ajcn.111.031427

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  54 in total

1.  Calcifediol versus vitamin D3 effects on gait speed and trunk sway in young postmenopausal women: a double-blind randomized controlled trial.

Authors:  O Meyer; B Dawson-Hughes; E Sidelnikov; A Egli; D Grob; H B Staehelin; G Theiler; R W Kressig; H P Simmen; R Theiler; H A Bischoff-Ferrari
Journal:  Osteoporos Int       Date:  2014-11-05       Impact factor: 4.507

2.  Individual participant data (IPD)-level meta-analysis of randomised controlled trials with vitamin D-fortified foods to estimate Dietary Reference Values for vitamin D.

Authors:  Kevin D Cashman; Mairead E Kiely; Rikke Andersen; Ida M Grønborg; Katja H Madsen; Janna Nissen; Inge Tetens; Laura Tripkovic; Susan A Lanham-New; Laura Toxqui; M Pilar Vaquero; Ulrike Trautvetter; Gerhard Jahreis; Vikram V Mistry; Bonny L Specker; Jürgen Hower; Anette Knoll; Dennis Wagner; Reinhold Vieth; Inger Öhlund; Pia Karlsland Åkeson; Neil R Brett; Hope A Weiler; Christian Ritz
Journal:  Eur J Nutr       Date:  2020-06-15       Impact factor: 5.614

Review 3.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

4.  Including food 25-hydroxyvitamin D in intake estimates may reduce the discrepancy between dietary and serum measures of vitamin D status.

Authors:  Christine L Taylor; Kristine Y Patterson; Janet M Roseland; Stephen A Wise; Joyce M Merkel; Pamela R Pehrsson; Elizabeth A Yetley
Journal:  J Nutr       Date:  2014-03-12       Impact factor: 4.798

5.  Maternal 25-hydroxycholecalciferol during lactation improves intestinal calcium absorption and bone properties in sow-suckling piglet pairs.

Authors:  Lianhua Zhang; Jiangxu Hu; Miao Li; Qinghui Shang; Sujie Liu; Xiangshu Piao
Journal:  J Bone Miner Metab       Date:  2019-07-09       Impact factor: 2.626

Review 6.  25-Hydroxyvitamin D as a Biomarker of Vitamin D Status and Its Modeling to Inform Strategies for Prevention of Vitamin D Deficiency within the Population.

Authors:  Kevin D Cashman; Ellen Ghm van den Heuvel; Ruud Jw Schoemaker; Damien P Prévéraud; Helen M Macdonald; Jayashree Arcot
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

7.  Ocular Pharmacokinetics of 25-Hydroxyvitamin D3 After Weekly Supplementation in Rabbits Using Ultra Performance Liquid Chromatography-Tandem Mass Spectrometer.

Authors:  Archit Kumar; Mini P Singh; Tripti Rungta; Ajay Patial; Savita Verma Attri; Bikash Medhi; Radha Kanta Ratho
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-10       Impact factor: 2.441

8.  Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.

Authors:  S Minisola; L Cianferotti; P Biondi; C Cipriani; C Fossi; F Franceschelli; F Giusti; G Leoncini; J Pepe; H A Bischoff-Ferrari; M L Brandi
Journal:  Osteoporos Int       Date:  2017-08-16       Impact factor: 4.507

9.  Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients.

Authors:  Sara Bañón; Marta Rosillo; Ana Gómez; María J Pérez-Elias; Santiago Moreno; José Luis Casado
Journal:  Endocrine       Date:  2014-11-29       Impact factor: 3.633

10.  The impact of 1-year vitamin D supplementation on vitamin D status in athletes: a dose-response study.

Authors:  E M P Backx; M Tieland; K Maase; A K Kies; M Mensink; L J C van Loon; L C P G M de Groot
Journal:  Eur J Clin Nutr       Date:  2016-07-27       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.